Prothena Corporation PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Prothena Corporation PLC with three other
companies in this sector in UNITED STATES :
Capricor Therapeutics Inc
sales of $1.01 million
Lumos Pharma Inc
of which 100%
was biopharmaceutical segment), and
During the year ended December of 2019, sales at
Prothena Corporation PLC were $814,000.00 .
decrease of 14.8%
versus 2018, when the company's sales were $955,000.00 .